Kentucky Women's Justice Community Overdose Innovation Network - Phase II
Michele Staton
300 participants
Jun 23, 2026
INTERVENTIONAL
Conditions
Summary
This project continues our work with women in the Kentucky Women's Justice Community Overdose Innovation Network Phase II (WJCOIN-II) with the overall aim of reducing overdose risk during the transition from jail to rural communities. WJCOIN-II has potential for significant impact regarding the effectiveness, implementation, and sustainability of innovative overdose prevention strategies during the high-risk time of community re-entry among vulnerable, CLS-involved women in rural communities. This research will impact the field by increasing the capacity of the criminal legal system to respond to the overdose crisis through increased access to prevention strategies to reduce overdose risk.
Eligibility
Inclusion Criteria5
- DSM-5 scores of 2+ for opioids (OUD) and/or stimulants (StUD),
- no evidence of cognitive impairment in providing consent,
- a release date within 7-60 days to allow for time for intervention sessions,
- willingness to consider SUD treatment post-release, and
- willingness to provide the name and contact information of at least one person in the community who will support the woman's recovery pre/post-release (SP).
Exclusion Criteria2
- Not living in a rural area
- Any condition that would not allow capable informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
WJCOIN-II's multi-level 2 X 2 randomized factorial design will examine the effectiveness of OPIP components across four study conditions randomly assigned after baseline data collection (n=75 per condition, 100 per jail site), summarized in Table 7 and described below. In addition to group assignment, outcomes will be assessed as a function of engagement in each intervention component defined as the number of sessions attended (RC and CM conditions) and perceived support, which is a count of the number of types of support provided by the RC and SP (e.g., emotional, financial, etc.).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07179614